Evanston, Illinois – September 17, 2026 -- ZS has been named a Leader in the IDC MarketScape: Worldwide Life Science R&D RWD/Real-World Evidence for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment (IDC #US54122226, August 2026).
The recognition marks ZS's second IDC MarketScape Leader designation in 2026, following its May 2026 placement as a Leader in the Worldwide Life Sciences R&D Strategic Consulting Services assessment (IDC #US53009826).
ZS reports 90% NPS and 97% retention across its real-world data and evidence engagements
IDC's assessment cited ZS's integrated Medical & Evidence practice, which links medical, real-world evidence and health economics and outcomes research (HEOR) strategies to speed decision-making. The firm connects evidence generation directly to downstream dissemination, supporting publications, congress strategies and field medical execution for life sciences clients.
ZS's Evidence Pro platform cut integrated evidence planning timelines from months to weeks
ZS's digital Integrated Evidence Planning (IEP) capability, delivered through ZS Evidence Pro, has produced over 250 IEPs to date. The platform reduced development time from four to five months per plan to generating more than 30 IEPs within 10 weeks, achieving a 75% acceptance rate across more than 20 protocol recommendations.
ZS's AI-enabled Patient Radar platform aided diagnosis of 26 rare-disease patients in 12 months
The company's ZAIDYN Medical platform bundles five modules -- Opinion Leader Intelligence, Care Gap Intelligence, Scientific Medical Intelligence, Medical Customer Engagement for medical science liaisons, and Patient Outcomes Impact analysis -- into a single medical intelligence system. Separately, ZS's Patient Radar tool, used to identify hard-to-find rare-disease patients and physicians, helped accurately diagnose 26 new patients over a 12-month period for a rare disease organization.
ZS Data Nexus becomes first RWE platform in Europe to secure Europrivacy certification
In Europe, ZS Data Nexus operates as a proprietary, regulatory-grade real-world data access platform. IDC noted it as the first RWE solution in the region to achieve Europrivacy certification, a distinction relevant to life sciences firms navigating EU data compliance requirements.
Rohan Fernando, managing principal of ZS's life sciences R&D and medical practice, said life sciences organizations are seeking more connected approaches to evidence and decision-making across the product life cycle, and that integrated evidence planning and connected evidence-generation capabilities help clients turn real-world data into decision-grade insights informing regulatory, medical and business decisions.